Kimberly Lezon-Geyda

1.4k total citations
34 papers, 860 citations indexed

About

Kimberly Lezon-Geyda is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Kimberly Lezon-Geyda has authored 34 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Hematology. Recurrent topics in Kimberly Lezon-Geyda's work include Erythrocyte Function and Pathophysiology (10 papers), HER2/EGFR in Cancer Research (6 papers) and Genomics and Chromatin Dynamics (6 papers). Kimberly Lezon-Geyda is often cited by papers focused on Erythrocyte Function and Pathophysiology (10 papers), HER2/EGFR in Cancer Research (6 papers) and Genomics and Chromatin Dynamics (6 papers). Kimberly Lezon-Geyda collaborates with scholars based in United States, Germany and Australia. Kimberly Lezon-Geyda's co-authors include Vincent Schulz, Patrick G. Gallagher, Yelena Maksimova, Lyndsay N. Harris, Edyta Glogowska, Vesna Najfeld, EM Johnson, David Tuck, Archibald S. Perkins and Yi Zhang and has published in prestigious journals such as Nucleic Acids Research, Circulation and Journal of Clinical Investigation.

In The Last Decade

Kimberly Lezon-Geyda

32 papers receiving 853 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimberly Lezon-Geyda United States 16 473 209 200 168 162 34 860
Nicholas C. Wolff United States 14 684 1.4× 169 0.8× 232 1.2× 328 2.0× 191 1.2× 15 1.2k
Silvana Di Giandomenico United States 10 537 1.1× 58 0.3× 184 0.9× 115 0.7× 263 1.6× 16 865
Gaia Roversi Italy 13 592 1.3× 52 0.2× 121 0.6× 139 0.8× 131 0.8× 18 960
Olga Sirin United States 7 367 0.8× 92 0.4× 173 0.9× 49 0.3× 207 1.3× 7 746
Matilda Rehn Sweden 12 382 0.8× 61 0.3× 292 1.5× 81 0.5× 179 1.1× 24 862
Abdullah Mahmood Ali United States 20 1.5k 3.1× 101 0.5× 309 1.5× 90 0.5× 244 1.5× 60 2.0k
François Morlé France 18 631 1.3× 223 1.1× 58 0.3× 91 0.5× 48 0.3× 49 1.1k
Floris P Barthel United States 8 541 1.1× 245 1.2× 296 1.5× 166 1.0× 167 1.0× 12 915
Carolina Vicente‐Dueñas Spain 18 728 1.5× 37 0.2× 244 1.2× 124 0.7× 495 3.1× 41 1.2k
Thibault Voeltzel France 16 898 1.9× 66 0.3× 236 1.2× 111 0.7× 546 3.4× 27 1.3k

Countries citing papers authored by Kimberly Lezon-Geyda

Since Specialization
Citations

This map shows the geographic impact of Kimberly Lezon-Geyda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Lezon-Geyda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Lezon-Geyda more than expected).

Fields of papers citing papers by Kimberly Lezon-Geyda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Lezon-Geyda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Lezon-Geyda. The network helps show where Kimberly Lezon-Geyda may publish in the future.

Co-authorship network of co-authors of Kimberly Lezon-Geyda

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly Lezon-Geyda. A scholar is included among the top collaborators of Kimberly Lezon-Geyda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly Lezon-Geyda. Kimberly Lezon-Geyda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chakraborty, Raja, Allison C. Ostriker, Yi Xie, et al.. (2022). Histone Acetyltransferases p300 and CBP Coordinate Distinct Chromatin Remodeling Programs in Vascular Smooth Muscle Plasticity. Circulation. 145(23). 1720–1737. 60 indexed citations
2.
Murphy, Zachary C., Kristin Murphy, Jacquelyn Myers, et al.. (2021). Regulation of RNA polymerase II activity is essential for terminal erythroid maturation. Blood. 138(18). 1740–1756. 14 indexed citations
3.
Gallagher, Patrick G., Yelena Maksimova, Kimberly Lezon-Geyda, et al.. (2019). Aberrant splicing contributes to severe α-spectrin–linked congenital hemolytic anemia. Journal of Clinical Investigation. 129(7). 2878–2887. 19 indexed citations
4.
Schulz, Vincent, Hongxia Yan, Kimberly Lezon-Geyda, et al.. (2019). A Unique Epigenomic Landscape Defines Human Erythropoiesis. Cell Reports. 28(11). 2996–3009.e7. 41 indexed citations
5.
Yang, Elizabeth, et al.. (2017). Hemoglobin C trait accentuates erythrocyte dehydration in hereditary xerocytosis. Pediatric Blood & Cancer. 64(8). 11 indexed citations
6.
Steiner, Laurie A., et al.. (2016). CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells. PLoS ONE. 11(5). e0155378–e0155378. 6 indexed citations
7.
Varadan, Vinay, Sitharthan Kamalakaran, Hannah Gilmore, et al.. (2015). Brief‐exposure to preoperative bevacizumab reveals a TGF‐β signature predictive of response in HER2‐negative breast cancers. International Journal of Cancer. 138(3). 747–757. 14 indexed citations
8.
Hatzis, Christos, Gina G. Chung, Kimberly Lezon-Geyda, et al.. (2015). Sirolimus and trastuzumab combination therapy for HER2-positive metastatic breast cancer after progression on prior trastuzumab therapy. Breast Cancer Research and Treatment. 150(1). 157–167. 25 indexed citations
9.
Weinstein, Jason S., Kimberly Lezon-Geyda, Yelena Maksimova, et al.. (2014). Global transcriptome analysis and enhancer landscape of human primary T follicular helper and T effector lymphocytes. Blood. 124(25). 3719–3729. 39 indexed citations
10.
Salzman, David W., Deirdre Wall, Catherine Sullivan, et al.. (2014). A germline mutation in the BRCA13’UTR predicts Stage IV breast cancer. BMC Cancer. 14(1). 421–421. 12 indexed citations
11.
Juneja, Subhash C., Alin Vonica, Caroline J. Zeiss, et al.. (2013). Deletion of Mecom in mouse results in early-onset spinal deformity and osteopenia. Bone. 60. 148–161. 17 indexed citations
12.
Lindner, Robert, Kimberly Lezon-Geyda, Neal Fischbach, et al.. (2013). Molecular Phenotypes in Triple Negative Breast Cancer from African American Patients Suggest Targets for Therapy. PLoS ONE. 8(11). e71915–e71915. 68 indexed citations
13.
Schulz, Vincent, Yelena Maksimova, Kimberly Lezon-Geyda, & Patrick G. Gallagher. (2013). The Patient With Transfusion-Dependent Anemia: Diagnosis and Directed Management With Targeted Next Generation Sequencing and Copy Number Analysis. Blood. 122(21). 3419–3419.
14.
Neumeister, Veronique, Catherine Sullivan, Robert Lindner, et al.. (2012). Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer. Breast Cancer Research and Treatment. 136(1). 67–75. 45 indexed citations
15.
Kamalakaran, Sitharthan, Kimberly Lezon-Geyda, Vinay Varadan, et al.. (2011). Evaluation of ER/PR and HER2 status by RNA sequencing in tissue core biopsies from preoperative clinical trial specimens.. Journal of Clinical Oncology. 29(27_suppl). 46–46. 2 indexed citations
16.
Li, Ao, Zongzhi Liu, Kimberly Lezon-Geyda, et al.. (2011). GPHMM: an integrated hidden Markov model for identification of copy number alteration and loss of heterozygosity in complex tumor samples using whole genome SNP arrays. Nucleic Acids Research. 39(12). 4928–4941. 67 indexed citations
17.
Zhang, Yi, Sandra Stehling-Sun, Kimberly Lezon-Geyda, et al.. (2011). PR-domain–containing Mds1-Evi1 is critical for long-term hematopoietic stem cell function. Blood. 118(14). 3853–3861. 81 indexed citations
18.
Najfeld, Vesna, et al.. (2003). Fluorescence in situ hybridization analysis of the PRV-1 gene in polycythemia vera. Experimental Hematology. 31(2). 118–121. 4 indexed citations
19.
Lezon-Geyda, Kimberly, Vesna Najfeld, & EM Johnson. (2001). Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia. Leukemia. 15(6). 954–962. 57 indexed citations
20.
Lezon-Geyda, Kimberly, James Godbold, Aluko A. Hope, et al.. (1996). Chrysotile asbestos fibers mediate homologous recombination in Rat2λ fibroblasts: implications for carcinogenesis. Mutation Research/Environmental Mutagenesis and Related Subjects. 361(2-3). 113–120. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicholas C. Wolff Breakdown of academic impact, for papers by Silvana Di Giandomenico Breakdown of academic impact, for papers by Gaia Roversi Breakdown of academic impact, for papers by Olga Sirin Breakdown of academic impact, for papers by Matilda Rehn Breakdown of academic impact, for papers by Abdullah Mahmood Ali Breakdown of academic impact, for papers by François Morlé Breakdown of academic impact, for papers by Floris P Barthel Breakdown of academic impact, for papers by Carolina Vicente‐Dueñas Breakdown of academic impact, for papers by Thibault Voeltzel
Rankless by CCL
2026